Optimised cefiderocol exposures in a successfully treated critically ill patient with polymicrobial Stenotrophomonas maltophilia bacteraemia and pneumonia receiving continuous venovenous haemodiafiltration

被引：17
作者：
Fratoni, Andrew J. [1 ]
Kuti, Joseph L. [1 ]
Nicolau, David P. [1 ]
机构：
[1] Hartford Hosp, Ctr Antiinfect Res & Dev, 80 Seymour St, Hartford, CT 06102 USA
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2021年 / 58卷 / 03期
关键词：
SIDEROPHORE CEPHALOSPORIN; PHARMACOKINETICS;
D O I：
10.1016/j.ijantimicag.2021.106395
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页数：2
相关论文
共 10 条
[1]   Comparative In Vivo Antibacterial Activity of Human-Simulated Exposures of Cefiderocol and Ceftazidime against Stenotrophomonas maltophilia in the Murine Thigh Model [J].
Chen, Iris H. ;
Kidd, James M. ;
Abdelraouf, Kamilia ;
Nicolaua, David P. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (12)
[2]  
CLSI, 2020, PERFORMANCE STANDARD, V30th ed.
[3]   In vitro antimicrobial activity of S-649266, a catechol-substituted siderophore cephalosporin, when tested against non-fermenting Gram-negative bacteria [J].
Ito, Akinobu ;
Kohira, Naoki ;
Bouchillon, Samuel K. ;
West, Joshua ;
Rittenhouse, Stephen ;
Sader, Helio S. ;
Rhomberg, Paul R. ;
Jones, Ronald N. ;
Yoshizawa, Hidenori ;
Nakamura, Rio ;
Tsuji, Masakatsu ;
Yamano, Yoshinori .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (03) :670-677
[4]   Cefiderocol, a Siderophore Cephalosporin for Gram-Negative Bacterial Infections: Pharmacokinetics and Safety in Subjects With Renal Impairment [J].
Katsube, Takayuki ;
Echols, Roger ;
Ferreira, Juan Camilo Arjona ;
Krenz, Heidi K. ;
Berg, Jolene Kay ;
Galloway, Christopher .
JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (05) :584-591
[5]   Population Pharmacokinetic and Pharmacokinetic/ Pharmacodynamic Analyses of Cefiderocol, a Parenteral Siderophore Cephalosporin, in Patients with Pneumonia, Bloodstream Infection/Sepsis, or Complicated Urinary Tract Infection [J].
Kawaguchi, Nao ;
Katsube, Takayuki ;
Echols, Roger ;
Wajima, Toshihiro .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (03)
[6]  
Matsumoto S, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/aac.00700-17, 10.1128/AAC.00700-17]
[7]   In Vivo Pharmacodynamic Study of Cefiderocol, a Novel Parenteral Siderophore Cephalosporin, in Murine Thigh and Lung Infection Models [J].
Nakamura, Rio ;
Ito-Horiyama, Tsukasa ;
Takemura, Miki ;
Toba, Shinsuke ;
Matsumoto, Shuhei ;
Ikehara, Tatsuya ;
Tsuji, Masakatsu ;
Sato, Takafumi ;
Yamano, Yoshinori .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (09)
[8]   Pharmacokinetics, Safety, and Tolerability of Cefiderocol, a Novel Siderophore Cephalosporin for Gram-Negative Bacteria, in Healthy Subjects [J].
Saisho, Yutaka ;
Katsube, Takayuki ;
White, Scott ;
Fukase, Hiroyuki ;
Shimada, Jingoro .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (03)
[9]  
Shionogi & Co. Ltd, 2020, CEF PACK INS
[10]   Pharmacokinetics of piperacillin and tazobactam in plasma and subcutaneous interstitial fluid in critically ill patients receiving continuous venovenous haemodiafiltration [J].
Varghese, Julie M. ;
Jarrett, Paul ;
Boots, Robert J. ;
Kirkpatrick, Carl M. J. ;
Lipman, Jeffrey ;
Roberts, Jason A. .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2014, 43 (04) :343-348
1